|
[1]
|
Jia, Y., Zhou, Z., Xiang, F., Hu, W. and Cao, X. (2024) Global Prevalence of Depression in Menopausal Women: A Systematic Review and Meta-Analysis. Journal of Affective Disorders, 358, 474-482. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
杨丽娜. 门诊围绝经期女性抑郁症状发生情况及影响因素分析[J]. 中国妇幼保健, 2022, 37(13): 2344-2347.
|
|
[3]
|
Radloff, L.S. (1977) The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement, 1, 385-401. [Google Scholar] [CrossRef]
|
|
[4]
|
Hamilton, M. (1960) A Rating Scale for Depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine, 16, 606-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zung, W.W.K. (1965) A Self-Rating Depression Scale. Archives of General Psychiatry, 12, 63-70. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kulkarni, J., Gavrilidis, E., Hudaib, A., Bleeker, C., Worsley, R. and Gurvich, C. (2018) Development and Validation of a New Rating Scale for Perimenopausal Depression—The Meno-D. Translational Psychiatry, 8, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Papazisis, G., Tsakiridis, Ι., Apostolopoulou, A., Papaefstathiou, E., Bellali, T., Liozidou, A., et al. (2022) The Greek Translation and Validation of the Electronic Version of the Meno-D Rating Scale for Post-Menopausal Depression. Health Informatics Journal, 28. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kim, N.Y., Yoo, S., Jin, J., Han, S., Hong, J.S. and Kim, S.M. (2023) Development and Verification of the Menopause Emotional Symptom Questionnaire. Menopause, 30, 961-968. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Maki, P.M., Kornstein, S.G., Joffe, H., Bromberger, J.T., Freeman, E.W., Athappilly, G., et al. (2018) Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Menopause, 25, 1069-1085. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Brown, L., Hunter, M.S., Chen, R., Crandall, C.J., Gordon, J.L., Mishra, G.D., et al. (2024) Promoting Good Mental Health over the Menopause Transition. The Lancet, 403, 969-983. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Harder, J.A., Fichorova, R.N., Srivastava, A., Wiley, A., Burdick, K.E., Locascio, J.J., et al. (2022) Brain-Derived Neurotrophic Factor and Mood in Perimenopausal Depression. Journal of Affective Disorders, 300, 145-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cheng, Y., Zhang, Z., Ma, X., Wang, X., Chen, L., Luo, Y., et al. (2024) The Association between Polycyclic Aromatic Hydrocarbons Exposure and Neuropsychiatric Manifestations in Perimenopausal Women: A Cross-Sectional Study. Journal of Affective Disorders, 344, 554-562. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
肖婷婷, 马骞. 围绝经期抑郁症患者Hcy、甲状腺激素水平表达及其抑郁严重程度的相关性[J]. 心理月刊, 2025, 20(2): 66-68.
|
|
[15]
|
Badawy, Y., Spector, A., Li, Z. and Desai, R. (2024) The Risk of Depression in the Menopausal Stages: A Systematic Review and Meta-Analysis. Journal of Affective Disorders, 357, 126-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Han, Y., Gu, S., Li, Y., Qian, X., Wang, F. and Huang, J.H. (2023) Neuroendocrine Pathogenesis of Perimenopausal Depression. Frontiers in Psychiatry, 14, Article ID: 1162501. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Musial, N., Ali, Z., Grbevski, J., Veerakumar, A. and Sharma, P. (2021) Perimenopause and First-Onset Mood Disorders: A Closer Look. Focus, 19, 330-337. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
de Novaes Soares, C., Almeida, O.P., Joffe, H. and Cohen, L.S. (2001) Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women: A Double-Blind, Randomized, Placebo-Controlled Trial. Archives of General Psychiatry, 58, 529-534. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Cohen, L.S., Soares, C.N., Poitras, J.R., Prouty, J., Alexander, A.B. and Shifren, J.L. (2003) Short-Term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: A Preliminary Report. American Journal of Psychiatry, 160, 1519-1522. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lee, D.Y., Andreescu, C., Aizenstein, H., Karim, H., Mizuno, A., Kolobaric, A., et al. (2023) Impact of Symptomatic Menopausal Transition on the Occurrence of Depression, Anxiety, and Sleep Disorders: A Real-World Multi-Site Study. European Psychiatry, 66, e80. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
MacQueen, G.M., Frey, B.N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R.J.V., et al. (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. The Canadian Journal of Psychiatry, 61, 588-603. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58(1): 4-21.
|
|
[23]
|
Yang, X. and Reckelhoff, J.F. (2011) Estrogen, Hormonal Replacement Therapy and Cardiovascular Disease. Current Opinion in Nephrology & Hypertension, 20, 133-138. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Xiang, X., Palasuberniam, P. and Pare, R. (2024) Exploring the Feasibility of Estrogen Replacement Therapy as a Treatment for Perimenopausal Depression: A Comprehensive Literature Review. Medicina, 60, Article No. 1076. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Hsiao, S.M. and Liao, S.C. (2023) Effect of Tibolone vs Hormone Replacement Therapy on Climacteric Symptoms and Psychological Distress. Journal of the Chinese Medical Association, 87, 189-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Sundström-Poromaa, I., Comasco, E., Sumner, R. and Luders, E. (2020) Progesterone—Friend or Foe? Frontiers in Neuroendocrinology, 59, Article ID: 100856. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Sovijit, W.N., Sovijit, W.E., Pu, S., Usuda, K., Inoue, R., Watanabe, G., et al. (2021) Ovarian Progesterone Suppresses Depression and Anxiety-Like Behaviors by Increasing the Lactobacillus Population of Gut Microbiota in Ovariectomized Mice. Neuroscience Research, 168, 76-82. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Susser, L.C. (2023) Clinical Implications of the Neurosteroid Allopregnanolone in Reproductive Depression. Harvard Review of Psychiatry, 31, 37-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Memi, E., Pavli, P., Papagianni, M., Vrachnis, N. and Mastorakos, G. (2024) Diagnostic and Therapeutic Use of Oral Micronized Progesterone in Endocrinology. Reviews in Endocrine and Metabolic Disorders, 25, 751-772. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Glynne, S., Kamal, A., Kamel, A.M., Reisel, D. and Newson, L. (2024) Effect of Transdermal Testosterone Therapy on Mood and Cognitive Symptoms in Peri-and Postmenopausal Women: A Pilot Study. Archives of Women’s Mental Health, 28, 541-550. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Huang, L., Sun, S., Jiang, G., Xie, G., Yang, Y., Chen, S., et al. (2024) Follicle-Stimulating Hormone Induces Depression-Like Phenotype by Affecting Synaptic Function. Frontiers in Molecular Neuroscience, 17, Article ID: 1459858. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Zheng, K., Gao, B., Wang, H., He, J., Chen, H., Hu, Z., et al. (2024) Melatonin Ameliorates Depressive‐Like Behaviors in Ovariectomized Mice by Improving Tryptophan Metabolism via Inhibition of Gut Microbe Alistipes inops. Advanced Science, 11, Article ID: 2309473. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Shea, A.K., Wolfman, W., Fortier, M. and Soares, C.N. (2021) Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. Journal of Obstetrics and Gynaecology Canada, 43, 1316-1323.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
梁开如, 蒋成刚. 更年期女性心理健康管理专家共识[J]. 中国妇幼健康研究, 2021, 32(8): 1083-1089.
|
|
[35]
|
Stute, P., Spyropoulou, A., Karageorgiou, V., Cano, A., Bitzer, J., Ceausu, I., et al. (2020) Management of Depressive Symptoms in Peri-and Postmenopausal Women: EMAS Position Statement. Maturitas, 131, 91-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Kornstein, S.G., Jiang, Q., Reddy, S., Musgnung, J.J. and Guico-Pabia, C.J. (2010) Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women with Major Depressive Disorder. The Journal of Clinical Psychiatry, 71, 1088-1096. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Clayton, A.H., Kornstein, S.G., Dunlop, B.W., Focht, K., Musgnung, J., Ramey, T., et al. (2013) Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women with Major Depressive Disorder. The Journal of Clinical Psychiatry, 74, 1010-1017. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Freeman, M.P., Hill, R. and Brumbach, B.H. (2006) Escitalopram for Perimenopausal Depression: An Open-Label Pilot Study. Journal of Women’s Health, 15, 857-861. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Freeman, M.P., Hirschberg, A.M., Wang, B., Petrillo, L.F., Connors, S., Regan, S., et al. (2013) Duloxetine for Major Depressive Disorder and Daytime and Nighttime Hot Flashes Associated with the Menopausal Transition. Maturitas, 75, 170-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Soares, C.N., Joffe, H., Viguera, A.C., Petrillo, L., Rydzewski, M., Yehezkel, R., et al. (2008) Paroxetine versus Placebo for Women in Midlife after Hormone Therapy Discontinuation. The American Journal of Medicine, 121, 159-162.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Zhang, X., Gao, L., Li, H., et al. (2020) The Effects of Duloxetine Combined with Olanzapine on Climacteric Depression and the Neuroendocrine System. International Journal of Clinical and Experimental Medicine, 13, 4354-4361.
|
|
[42]
|
Johnson, A., Roberts, L. and Elkins, G. (2019) Complementary and Alternative Medicine for Menopause. Journal of Evidence-Based Integrative Medicine, 24. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
周倩如, 张立秀, 顾清昕, 等. 认知行为疗法在老年抑郁症患者中的临床护理观察[J]. 心理月刊, 2025, 20(5): 150-152+158.
|
|
[44]
|
Kim, J. and Yu, H. (2024) The Effectiveness of Cognitive Behavioral Therapy on Depression and Sleep Problems for Climacteric Women: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 13, Article No. 412. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Smith-Francis, M.J. (2024) Complementary and Alternative Medicine for Menopause. Nursing Clinics of North America, 59, 551-562. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Gordon, J.L., Halleran, M., Beshai, S., Eisenlohr-Moul, T.A., Frederick, J. and Campbell, T.S. (2021) Endocrine and Psychosocial Moderators of Mindfulness-Based Stress Reduction for the Prevention of Perimenopausal Depressive Symptoms: A Randomized Controlled Trial. Psychoneuroendocrinology, 130, Article ID: 105277. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Wang, H., Wang, H., Kwok, J.Y.Y., Tang, S. and Sun, M. (2025) The Effectiveness of Mindfulness-Based Interventions on Menopausal Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Affective Disorders, 381, 337-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Jang, H., Bae, J.H., Kim, M., Park, M.Y., Kim, H.R. and Lee, Y. (2020) Agrimonia Pilosa Ledeb. Ameliorates Hyperglycemia and Hepatic Steatosis in Ovariectomized Rats Fed a High-Fat Diet. Nutrients, 12, Article No. 1631. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Pannu, A., Sharma, P.C., Thakur, V.K. and Goyal, R.K. (2021) Emerging Role of Flavonoids as the Treatment of Depression. Biomolecules, 11, Article No. 1825. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Khanna, A., John, F., Das, S., Thomas, J., Rao, J., Maliakel, B., et al. (2020) Efficacy of a Novel Extract of Fenugreek Seeds in Alleviating Vasomotor Symptoms and Depression in Perimenopausal Women: A Randomized, Double‐Blinded, Placebo‐Controlled Study. Journal of Food Biochemistry, 44, e13507. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Yao, G., Bai, Z., Niu, J., Zhang, R., Lu, Y., Gao, T., et al. (2022) Astragalin Attenuates Depression-Like Behaviors and Memory Deficits and Promotes M2 Microglia Polarization by Regulating IL-4R/JAK1/STAT6 Signaling Pathway in a Murine Model of Perimenopausal Depression. Psychopharmacology, 239, 2421-2443. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Wang, G., Li, Y., Lei, C., Lei, X., Zhu, X., Yang, L., et al. (2021) Quercetin Exerts Antidepressant and Cardioprotective Effects in Estrogen Receptor Α-Deficient Female Mice via BDNF-AKT/ERK1/2 Signaling. The Journal of Steroid Biochemistry and Molecular Biology, 206, Article ID: 105795. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Wang, D., Yu, Z., Yao, R., Zhang, J., Cui, W., Dai, J., et al. (2024) Quercetin Alleviates Depressive-Like Behavior by Modulating Acetyl-H3k9 Mediated Ferroptosis Pathway in Hypothalamus of Perimenopausal Depression Rat Model. Biomedicine & Pharmacotherapy, 179, Article ID: 117369. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Yao, R., Cui, W., Wang, W., Feng, C., Chen, Y. and Zhao, X. (2025) Metabolomics Revealed That Quercetin Improved Spleen Metabolism Disorders and Regulated the Brain-Spleen Axis in Perimenopausal Depression Model Rats. Journal of Pharmaceutical and Biomedical Analysis, 258, Article ID: 116744. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Kachko, V.A., Shulman, L.P., Kuznetsova, I.V., Uspenskaya, Y.B. and Burchakov, D.I. (2024) Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen® and Smart B® in Women with Climacteric Syndrome in Perimenopause. Advances in Therapy, 41, 3183-3195. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Cicero, A.F.G. and Minervino, A. (2022) Combined Action of SAMe, Folate, and Vitamin B12 in the Treatment of Mood Disorders: A Review. European Review for Medical and Pharmacological Sciences, 26, 2443-2459.
|
|
[57]
|
Chen, R., Tang, R., Zhang, S., Wang, Y., Wang, R., Ouyang, Y., et al. (2020) Xiangshao Granules Can Relieve Emotional Symptoms in Menopausal Women: A Randomized Controlled Trial. Climacteric, 24, 246-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Huang, R., Gong, M., Tan, X., Shen, J., Wu, Y., Cai, X., et al. (2023) Effects of Chaihu Shugan San on Brain Functional Network Connectivity in the Hippocampus of a Perimenopausal Depression Rat Model. Molecular Neurobiology, 61, 1655-1672. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Jiang, W., Jiang, X., Hu, W. and Wang, H. (2024) Tao-Hong-Si-Wu-Tang Improves the Depressive-Like Behaviors in Mice Experiencing Perimenopausal Depression through Modulating Activity of the Hypothalamic-Pituitary-Adrenal-Ovary Axis and Activating the BDNF-TrkB-CREB Signaling Pathway. Journal of Medicinal Food, 27, 669-680. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Lei, H., Liu, J., Deng, J., Zou, P., Zou, Z., Li, Z., et al. (2024) Behavior, Hormone, and Gut Microbiota Change by YYNS Intervention in an OVX Mouse Model. Frontiers in Cellular and Infection Microbiology, 14, Article ID: 1445741. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Zhang, L., Li, J., Chen, Q., Di, L. and Li, N. (2021) Erxian Decoction, a Famous Chinese Medicine Formula, Ameliorate Depression-Like Behavior in Perimenopausal Mice. Endocrine, Metabolic & Immune Disorders—Drug Targets, 21, 2203-2212. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Zheng, L., Sun, Z., Liu, C., Zhang, J., Jin, Y. and Jin, H. (2023) Acupuncture-Adjuvant Therapies for Treating Perimenopausal Depression: A Network Meta-Analysis. Medicine, 102, e34694. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Zhao, F., Zheng, Z., Fu, Q., Conduit, R., Xu, H., Wang, H., et al. (2023) Acupuncture for Comorbid Depression and Insomnia in Perimenopause: A Feasibility Patient-Assessor-Blinded, Randomized, and Sham-Controlled Clinical Trial. Frontiers in Public Health, 11, Article ID: 1120567. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Zhao, F.Y., Fu, Q.Q., Kennedy, G.A., Conduit, R., Zhang, W. and Zheng, Z. (2021) Acupuncture as an Independent or Adjuvant Management to Standard Care for Perimenopausal Depression: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry, 12, Article ID: 666988. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
沈非儿, 蒋亚文. 疏肝健脾解郁汤联合针灸治疗围绝经期抑郁症患者的效果研讨[J]. 内蒙古中医药, 2025, 44(2): 42-43.
|
|
[66]
|
Wang, J., Liao, Y., You, Y., Liang, W., Wan, L., Yang, H., et al. (2023) Acupuncture and Chinese Herbal Medicine for Menopausal Mood Disorder: A Randomized Controlled Trial. Climacteric, 26, 392-400. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Susanti, H.D., Sonko, I., Chang, P., Chuang, Y. and Chung, M. (2022) Effects of Yoga on Menopausal Symptoms and Sleep Quality across Menopause Statuses: A Randomized Controlled Trial. Nursing & Health Sciences, 24, 368-379. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Liu, X.Y., Peng, S.Z., Pei, M.Y. and Zhang, P. (2023) The Effects of Physical Activity on Depression and Quality of Life in Chinese Perimenopausal Women. Journal of Affective Disorders, 328, 153-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Mahdavipour, F., Rahemi, Z., Sadat, Z. and Ajorpaz, N.M. (2019) The Effects of Foot Reflexology on Depression during Menopause: A Randomized Controlled Clinical Trial. Complementary Therapies in Medicine, 47, Article ID: 102195. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Liu, J., Si, J. and Zhao, W. (2024) Investigation of the Effect of Tai Chi Training on Depressive Symptoms in Perimenopausal Women on the Basis of Serum Kynurenine Metabolites. Experimental Aging Research, 51, 331-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
张迪, 陈莹, 丁会, 等. 盐酸氟西汀联合戊酸雌二醇治疗围绝经期抑郁障碍患者的疗效研究[J]. 中国现代医生, 2024, 62(30): 75-78+86.
|
|
[72]
|
王宾红, 蔡杰, 张玥红. 雌二醇片/雌二醇地屈孕酮片联合心理干预对围绝经期伴焦虑、抑郁患者的效果[J]. 国际精神病学杂志, 2024, 51(2): 548-551+556.
|
|
[73]
|
成俊英. 黛力新治疗围绝经期妇女焦虑伴抑郁症的临床疗效及对医院焦虑/抑郁情绪测定量表和汉密尔顿-抑郁量表评分的影响[J]. 中国妇幼保健, 2023, 38(13): 2486-2490.
|